SEC Filings

Form 424B3 KAZIA THERAPEUTICS LTD May 23, 2024 07:04AM

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-276774

PROSPECTUS SUPPLEMENT

(to Prospectus dated February 5, 2024)

4,755,556 American Depositary Shares representing 47,555,560 Ordinary Shares

 

Kazia Therapeutics Limited

 

 

This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated February 5, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form F-1... (continue reading...)

Form 8-K Foghorn Therapeutics For: May 23 May 23, 2024 07:03AM false000182246200018224622024-05-232024-05-23UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________FORM 8-K________________________________________________________________________________________________CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2024... (continue reading...)

Form 6-K Aris Mining Corp For: May 23 May 23, 2024 07:02AM

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2024

Commission File Number: 001-41794

Aris Mining Corporation (Translation of registrant's name into English)

Suite 2400 - 1021 West Hastings St., Vancouver, BC, Canada V6C 0C3

(Address of principal executive offices)

 

Indicate by check mark... (continue reading...)

Form 6-K Evogene Ltd. For: May 23 May 23, 2024 07:01AM UNITED STATES  SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934   For the month of May 2024   Commission File Number: 001-36187 EVOGENE LTD.   (Translation of Registrant’s... (continue reading...)

Form 6-K KAZIA THERAPEUTICS LTD For: May 23 May 23, 2024 07:01AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May, 2024

Commission File Number 000-29962

 

 

Kazia Therapeutics Limited

(Translation of registrant’s name into English)

 

 

Three International Towers Level 24 300 Barangaroo Avenue Sydney NSW 2000

(Address of principal executive... (continue reading...)